Matthew Redinbo

PhD, Chemistry, UNC-Chapel Hill, Molecular Therapeutics

UNC-Chapel Hill
Molecular Therapeutics

Area of interest

Redinbo Laboratory uses the tools of structural, molecular and chemical biology to examine a range of dynamic cellular processes central to human health.

Current projects include the discovery of new antimicrobials targeted to drug-resistant bacteria, the design of novel proteins engineered to detect and eliminate toxic chemicals, and the development of small-molecule to cell-based methods to improve anticancer chemotherapeutics.

We also continue our focus on determining the crystal structures of macromolecular complexes, including those involving human nuclear receptors central to transcriptional regulation, bacterial proteins involved in DNA manipulation and human cell contact, and enzymes central to key cellular processes.

Awards and Honors

Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement, 2004.
Burroughs Wellcome Career Award in the Biomedical Sciences, 1999-2004.

Reach NC Profile

Find publications on Pubmed